Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/178725
Title: | Benzofuranyl-2-imidazoles as imidazoline I2 receptor ligands for Alzheimer's disease |
Author: | Rodríguez-Arévalo, Sergio Bagan Polonio, Andrea Griñán Ferré, Christian Vasilopoulou, Foteini Pallàs i Llibería, Mercè, 1964- Brocos-Mosquera, Iria Callado, Luis F. Loza, María Isabel Martínez, Antón L. Brea, José Pérez, Belén Molins i Grau, Elies Jonghe, Steven de Daelemans, Dirk Radan, Milica Djikic, Teodora Nikolic, Katarina Hernández-Hernández, Elena García-Fuster, M. Julia García-Sevilla, Jesús A. Escolano Mirón, Carmen |
Keywords: | Malaltia d'Alzheimer Malalties neurodegeneratives Envelliment Alzheimer's disease Neurodegenerative Diseases Aging |
Issue Date: | 22-Jun-2021 |
Publisher: | Elsevier Masson SAS |
Abstract: | Recent findings unveil the pharmacological modulation of imidazoline I2 receptors (I2-IR) as a novel strategy to face unmet medical neurodegenerative diseases. In this work, we report the chemical characterization, three-dimensional quantitative structure-activity relationship (3D-QSAR) and ADMET in silico of a family of benzofuranyl-2-imidazoles that exhibit affinity against human brain I2-IR and most of them have been predicted to be brain permeable. Acute treatment in mice with 2-(2-benzofuranyl)-2- imidazole, known as LSL60101 (garsevil), showed non-warning properties in the ADMET studies and an optimal pharmacokinetic profile. Moreover, LSL60101 induced hypothermia in mice while decreased pro-apoptotic FADD protein in the hippocampus. In vivo studies in the familial Alzheimer's disease 5xFAD murine model with the representative compound, revealed significant decreases in the protein expression levels of antioxidant enzymes superoxide dismutase and glutathione peroxidase in hippocampus. Overall, LSL60101 plays a neuroprotective role by reducing apoptosis and modulating oxidative stress. |
Note: | Versió postprint del document publicat a: https://doi.org/10.1016/j.ejmech.2021.113540 |
It is part of: | European Journal of Medicinal Chemistry, 2021, vol. 222, p. 113540 |
URI: | http://hdl.handle.net/2445/178725 |
Related resource: | https://doi.org/10.1016/j.ejmech.2021.113540 |
ISSN: | 0223-5234 |
Appears in Collections: | Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
712952.pdf | 2.08 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.